Job Description
CRA II, Home-based role ideally in Sydney, Melbourne and Brisbane
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
**Title: CRA II**
**Location: Australia**
As a CRA II at ICON, you will design and analyse clinical trials, interpreting complex medical data, and contribute to the advancement of innovative treatments and therapies.
**What You Will Do:**
You will contribute to clinical trial monitoring activities, taking responsibility for your deliverables and working collaboratively.
Key responsibilities include:
+ Conducting site qualification, initiation, monitoring, and close-out visits for clinical trials.
+ Ensuring protocol compliance, data integrity, and patient safety throughout the trial process.<...
ICON plc is a world-leading healthcare intelligence and clinical research organization. We’re proud to foster an inclusive environment driving innovation and excellence, and we welcome you to join us on our mission to shape the future of clinical development.
**Title: CRA II**
**Location: Australia**
As a CRA II at ICON, you will design and analyse clinical trials, interpreting complex medical data, and contribute to the advancement of innovative treatments and therapies.
**What You Will Do:**
You will contribute to clinical trial monitoring activities, taking responsibility for your deliverables and working collaboratively.
Key responsibilities include:
+ Conducting site qualification, initiation, monitoring, and close-out visits for clinical trials.
+ Ensuring protocol compliance, data integrity, and patient safety throughout the trial process.<...
Ready to Apply?
Submit your application today and join our talented team at ICON Clinical Research.
Submit ApplicationJob Details
- Location Remote, Australia
- Job Type Full-time
- Category other-general
- Posted Date May 28, 2026
- Application Deadline June 08, 2026